Abstract:Human cerebrospinal fluid (CSF), produced by the choroid plexus and secreted into the brain ventricles and subarachnoid space, plays critical roles in intra-cerebral transport and the biophysical and immune protection of the central nervous system (CNS). CSF composition provides valuable insight into soluble pathogenic bio-markers that may be diagnostic for neurodegenerative disease. In these experiments we analyzed amyloid beta (Aβ) peptide and micro RNA (miRNA) abundance (i) in CSF, (ii) in short post-mortem interval brain tissue-derived extracellular fluid (ECF) and (iii) in brain tissue biopsy derived from Alzheimer's disease (AD) or age-matched control neocortex and/or hippocampal CA1. 3'-untranslated region (3'-UTR) sequence/vector analysis; Aβ42-peptide+TNFα-induced and/or hydrogen peroxide-induced stress; bioinformatics; CAPE, CAY10512, DNA array; DNA/RNA sequencing; human brain biopsy/postmortem tissue; human CSF;LED-Northern micro-dot blot analysis; micro-RNA array; protected anti-miRNAs; RT-PCR; statistical analysis, β-actin, TREM-2- and CFH-3'-UTR-luciferase-reporter transfection assay; UV/fluorescent microscopy; Western immuno-histochemistry. There was a trend for decreased-abundance of Aβ42 in the CSF and ECF in AD but it did not reach statistical significance (mean-age ∼72 yr; N=12; p∼0.06, ANOVA). The most abundant nucleic acids in AD-CSF and ECF were miRNAs and their speciation, abundance and inducibility were studied further. Comparison of miRNA signals between biopsy and post-mortem tissues (0.5–6 hrs) indicated a short half-life for many brain-enriched miRNAs. Fluorescent miRNA-array-based analysis indicated significant increases in miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155. Increases in miRNAs were confirmed independently using a highly-sensitive LED-Northern dot-blot assay. Primary human neuronal-glial cell co-cultures stressed with AD-derived ECF, TNFα or peroxide also displayed an up-regulation of these and other miRNAs. These effects were quenched using the anti-NF-КB agents caffeic acid-phenethyl-ester (CAPE) or 1-fluoro-2-[2-(4-methoxy-phenyl)-ethenyl]-benzene (CAY10512). The results indicate that miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a and miRNA-155 are a family of inducible, NF-КB-sensitive pro-inflammatory miRNAs that are abundant in AD tissues and fluids. These AD-upregulated miRNAs further associate with deficits in the innate-immune response and the chronic and progressive spreading of inflammatory neurodegeneration. Enrichment of these miRNAs in circulating CSF and ECF suggest that they may be involved in the proliferation of miRNA-triggered pathogenic signaling throughout the AD brain and CNS.

MicroRNA Expression Analysis of Adult-onset Drosophila Alzheimer’s Disease Model

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

The Role of Mir-124 in Drosophila Alzheimer&#39;s Disease Model by Targeting Delta in Notch Signaling Pathway

Differential gene expression by RNA-seq during Alzheimer's disease-like progression in the Drosophila melanogaster model

Behavioural Effects and RNA-seq Analysis of Aβ42-Mediated Toxicity in a Drosophila Alzheimer's Disease Model

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

Studying Alzheimer’s Disease Using &lt;i&gt;drosophila Melanogaster&lt;/i&gt; As a Powerful Tool

Establishment of a Drosophila AD Model

High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model

MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?

Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer’s Disease Using Bioinformatic Analyses

Differential microRNA expression analyses across two brain regions in Alzheimer's disease

Analysis of Serum miRNAs in Alzheimer's Disease.

Preliminary exploration of the co-regulation of Alzheimer's disease pathogenic genes by microRNAs and transcription factors

Peripheral Blood MicroRNA Expression Profiles in Alzheimer’s Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism

Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis

MicroRNA Complexity in Alzheimer's Disease Cerebrospinal Fluid, Extracellular Fluid and Brain Tissue Biopsy

Systems genetic dissection of Alzheimer's disease brain gene expression networks

MicroRNAs in Alzheimer's Disease: Function and Potential Applications As Diagnostic Biomarkers.